By the end of 2022, the positive air pressure devices market sales is expected to have grown from its US$ 2.3 billion valuation in 2021 to US$ 2.5 billion. Apart from that, the overall demand for positive air pressure devices is anticipated to increase due to their growing use in treating medical conditions like sleep apnea and respiratory failures. This demand is predicted to grow at a compound annual growth rate (CAGR) of 6.4% between 2022 and 2032, reaching a market valuation of US$ 4.7 billion by that year.
Global Positive Air Pressure Devices Market: Dynamics Influencing Growth
Favourable reimbursement coverage, increasing per capita healthcare expenditure, increasing prevalence of sleep disorders, rising awareness regarding the ill effects of untreated sleep apnea, increase in geriatric population, increase in obstructive sleep apnea, and increasing number of lifestyle diseases such as diabetes and obesity are favourable for the growth of the global positive air pressure devices market. However, alternative treatments for sleep apnea, lack of public awareness especially in the developing economies and pricing pressure are responsible restricting the growth of the global positive air pressure devices market.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5623
Global Positive Air Pressure Devices Market: Segmentation Snapshot
The global market for positive air pressure devices is segmented by product type, by application type, by end user and by region.
By product type, the continuous positive airway pressure devices (CPAP) segment is expected to be the largest, with an estimated market valuation of just under US$ 2.4 Bn by the end of the forecast period in 2027.
By application type, obstructive sleep apnea is the largest segment and is expected to reach a value of around US$ 2.2 Bn by the end of the year of assessment at a stellar growth rate during the forecast period. The respiratory failures segment is the fastest growing segment registering a CAGR of 7.4% and is anticipated to hold high potential in the coming years.
By end user, hospitals have shown higher use of positive air pressure devices and this segment is estimated to be valued at about US$ 1,135 Mn by 2017 end. Home care settings segment is projected to be the fastest growing segment and is poised to reflect a CAGR of 8.8% and is the second largest segment in terms of value during the assessment period.
Among the regions, the positive air pressure devices market in Asia Pacific excluding Japan (APEJ) is poised to grow at the fastest rate to reach a noteworthy CAGR of 10.6% during the forecast period. By the end of 2027, Western Europe is expected to be the largest regional market in terms of valuation followed by North America.
Global Positive Air Pressure Devices Market: Competitive Assessment
The research report on the global air pressure devices market includes profiles of key players involved in the positive air pressure devices market. Company details such as company overview, key personnel, strategies, key financials, SWOT analysis, key developments, product portfolio analysis and geographical spread are mentioned in the report. Major players like ResMed Inc., Koninklijke Philips N.V., APEX MEDICAL CORP., Drive DeVilbiss Healthcare LLC, Medtronic, Inc., Fisher & Paykel Healthcare Limited, BMC Medical Co., Ltd., Khayat Medical, Servona GmbH, Somnetics International, Inc., 3B Medical, Inc., and Human Design Medical are profiled in this study.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5623
Market Segmentation
The global positive air pressure devices market research report covers all angles by including a robust segmentation of the entire market. This ensures no aspect is left behind and a more real picture of the market can be drawn.
By Product Type:
- Continuous Positive Airways Pressure Devices (CPAP)
- Bi-level Positive Airway Pressure (BiPAP)/Variable Positive Airway Pressure (VPAP)
- Automatic Positive Airway Pressure Devices (APAP)
By End User:
- Hospitals
- Clinics
- Home Care Settings
- Others
By Application Type:
- Obstructive Sleep Apnea
- Respiratory Failures
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan (APEJ)
- Japan
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube